A detailed history of Two Sigma Securities, LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 12,554 shares of ENTX stock, worth $24,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,554
Holding current value
$24,605
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$1.7 - $2.72 $21,341 - $34,146
12,554 New
12,554 $21,000
Q4 2023

Feb 14, 2024

BUY
$0.55 - $0.74 $38,192 - $51,386
69,441 New
69,441 $41,000

Others Institutions Holding ENTX

About Entera Bio Ltd.


  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $56.5M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.